{"release":{"id":"7a41a2cc5aaf78412593b2d310cf279f6d209fcbf373aa170d236de8b21d8f21","published":"2026-11-17T06:41:06Z","pinned":false},"limits":{"coverage":{"history":"full","held_since":"2023-06-09","gaps":[],"covered":["MiCA L1"],"not_covered":["national guidance","court decisions"]},"freshness":{"release_id":"7a41a2cc5aaf78412593b2d310cf279f6d209fcbf373aa170d236de8b21d8f21","release_published":"2026-11-17T06:41:06Z","checked_at":null,"checked_against":null},"truncation":null,"failures":[],"incomplete":[]},"page":{"path":"/mica/level-3/q-and-a/eba","url":"https://www.headlesslaw.com/mica/level-3/q-and-a/eba","title":"EBA","family":"landing","work_id":"mica","status":"in_force","force_status":null,"date_state":"current","requested_date":null,"as_of":"2026-11-18","applies_from":null,"application":null,"version_label":null,"check":null,"check_result":null,"official_url":null,"valid_from":null,"valid_until":null,"revision":null,"content_id":null,"change_date":null,"nearest_versions":[],"first_text_date":null,"correction_applies":false,"versions":[],"version_url":null,"revision_url":null,"versions_url":null,"relations_url":null,"source_line":null,"attribution":null},"provenance":{"official_url":null,"check":{"result":null,"checked_at":null,"against":null},"repo_path":null,"body_sha256":"8920ca5d5ba6e5517c09f52df8dfcfe2c9fc4b5b662eabc5ca09d06c469a8950","markdown_sha256":"2dc54e7e5a86b48fbc8db60a036d3b8e4474c6604eec1c11e0966018d3d2442a"},"units":[],"markdown":"EBA under MiCA, ordered by official identifier.\n\n- [EBA Q&A 2024_7027 — Q&A — CASP: non-EUR EMT trading \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7027-casp-non-eur-emt-trading)\n- [EBA Q&A 2024_7066 — Q&A — ART reserve: bail-in eligibility \\[Question under review\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7066-art-reserve-bail-in-eligibility)\n- [EBA Q&A 2024_7067 — Q&A — MiCAR vs CRD: recovery plan info \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7067-micar-vs-crd-recovery-plan-info)\n- [EBA Q&A 2024_7068 — Q&A — EMT parallel issuance: EU and non-EU \\[Question under review\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7068-emt-parallel-issuance-eu-non-eu)\n- [EBA Q&A 2024_7069 — Q&A — Scope of Recital 54 and Article 54 \\[Question under review\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7069-recital-54-article-54-significance)\n- [EBA Q&A 2024_7078 — Q&A — EMT issuers: AML/KYC obligations \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7078-emt-issuer-aml-kyc-scope)\n- [EBA Q&A 2024_7084 — Q&A — Should exchanging EMTs for other crypto-assets \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7084-emt-exchange-qualification)\n- [EBA Q&A 2024_7114 — Q&A — Gold tokens as ARTs \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7114-gold-tokens-arts)\n- [EBA Q&A 2024_7166 — Q&A — White paper obligation for exempt ART issuers \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7166-whitepaper-publication-exempted-issuers)\n- [EBA Q&A 2024_7167 — Q&A — Passporting procedure for non-CI ART issuers \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7167-passporting-art-issuers)\n- [EBA Q&A 2024_7168 — Q&A — CI/EMI passporting for ART/EMT \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7168-passporting-ci-emi-token-issuers)\n- [EBA Q&A 2024_7172 — Q&A — Lightning Network: TFR/Travel Rule scope for CASPs \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7172-lightning-network-travel-rule)\n- [EBA Q&A 2024_7185 — Q&A — ART/EMT: scope of public offering \\[Final Q&A\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7185-scope-public-offering-art-emt)\n- [EBA Q&A 2024_7210 — Q&A — Own funds for issuers exempt from authorisation \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7210-own-funds-art-issuers-exempt)\n- [EBA Q&A 2025_7457 — Q&A — PSD2 applicability to EMT issuance/redemption \\[Question under review\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7457-psd2-applicability-emt-issuance)\n- [EBA Q&A 2025_7591 — Q&A — EMT issuance: bank segregated account \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7591-emt-issuance-bank-segregated-account)\n- [EBA Q&A 2026_7834 — Q&A — Own funds: overlapping CASP/EMI/IF authorisations \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7834-own-funds-overlapping-casp-emi-if)\n- [EBA Q&A 2026_7968 — Q&A — NCA power to increase own funds or reserve assets \\[Rejected question\\]](https://www.headlesslaw.com/mica/level-3/q-and-a/eba/eba-qa-7968-nca-power-increase-own-funds-reserve-assets)\n"}